I have entered into four new short positions this morning, focused on semiconductors. In each case, my stop-loss is set where I’ve drawn the dashed red line (typically a price gap or the recent “lower high” for the stock.

Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
I have entered into four new short positions this morning, focused on semiconductors. In each case, my stop-loss is set where I’ve drawn the dashed red line (typically a price gap or the recent “lower high” for the stock.

Normally, the day after NVDA reports is almost completely obsessed with, well, Nvidia. This time, however, the NVDA earnings got subsumed by the huge news about the international trade court, which has absolutely rolled the markets.
Now that the dust has settled, I wanted to mention that I actually went short NVDA yesterday, to good effect thus far. The stock has been hammering out a series of lower highs, and the peak yesterday matched almost to the penny the prior lower high. I figure if THAT much good news (blowout earnings and the trade court thing) could only push the stock to that level, not even in the same ZIP code as lifetime highs, it was time to get short.

In a world where everything is so overvalued (only relative to fundamentals like P/E ratios if you follow that sort of thing), what’s left to actually buy?
Well, I’ve always found that when in doubt, you can go back to wading through the OGs of meme stocks, i.e., biotech. There’s been a lot of action lately that, to those paying attention, there is a lot of short-term quick “opportunities”.
I put that in quotes because playing bio tech stocks can be very addictive if you aren’t following appropriate rules. These are essentially lottery plays, hence the title of this post. That is not to say that true opportunity doesn’t exist. But you need to keep a book level mentality when playing them because some may not work out at all. They are volatile and susceptible to sudden gap downs if/when some products may not get that FDA approval they were waiting on or some lawsuit comes out against their primary (or sometimes only) product.
(more…)My wife loves her Hokas…….

One BBB has replaced another. The Big Beautiful Bill has curb-stomped Build Back Better, and in doing so, solar credits have been laid waste. Here’s a look at the carnage.
